These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 33232910)

  • 1. The m
    Ma L; Chen T; Zhang X; Miao Y; Tian X; Yu K; Xu X; Niu Y; Guo S; Zhang C; Qiu S; Qiao Y; Fang W; Du L; Yu Y; Wang J
    Redox Biol; 2021 Jan; 38():101801. PubMed ID: 33232910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting SLC3A2 subunit of system X
    Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
    Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12.
    Sun Y; Liu Y; Wang P; Chang L; Huang J
    Mol Biotechnol; 2024 May; 66(5):1051-1061. PubMed ID: 38129673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The essential roles of m
    Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
    Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
    Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of m
    Wang J; Tan L; Jia B; Yu X; Yao R; OUYang N; Yu X; Cao X; Tong J; Chen T; Chen R; Li J
    Int J Biol Sci; 2021; 17(10):2633-2651. PubMed ID: 34326699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of m
    Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
    Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
    Hu K; Li K; Lv J; Feng J; Chen J; Wu H; Cheng F; Jiang W; Wang J; Pei H; Chiao PJ; Cai Z; Chen Y; Liu M; Pang X
    J Clin Invest; 2020 Apr; 130(4):1752-1766. PubMed ID: 31874110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of the m
    Yin Z; Ma L; Tian X; Sun Q; Zhang C; Wang Y; Miao Y; Xue X; Wang Y; Wang J; Zhang X; Hou X
    J Biol Chem; 2024 Oct; 300(10):107783. PubMed ID: 39303913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
    Teng Y; Zhao X; Xi Y; Fu N
    Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LIM-domain binding protein 2 regulated by m
    Zhai D; Wang G; Li L; Jia X; Zheng G; Yin J
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):329-335. PubMed ID: 33849822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m
    Lin X; Ye R; Li Z; Zhang B; Huang Y; Du J; Wang B; Meng H; Xian H; Yang X; Zhang X; Zhong Y; Huang Z
    Drug Resist Updat; 2023 Jan; 66():100908. PubMed ID: 36493511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The m
    Kretschmer J; Rao H; Hackert P; Sloan KE; Höbartner C; Bohnsack MT
    RNA; 2018 Oct; 24(10):1339-1350. PubMed ID: 29970596
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
    Zhang X; Yu K; Ma L; Qian Z; Tian X; Miao Y; Niu Y; Xu X; Guo S; Yang Y; Wang Z; Xue X; Gu C; Fang W; Sun J; Yu Y; Wang J
    Theranostics; 2021; 11(12):5650-5674. PubMed ID: 33897873
    [No Abstract]   [Full Text] [Related]  

  • 15. N
    Zhou B; Liu C; Xu L; Yuan Y; Zhao J; Zhao W; Chen Y; Qiu J; Meng M; Zheng Y; Wang D; Gao X; Li X; Zhao Q; Wei X; Wu D; Zhang H; Hu C; Zhuo X; Zheng M; Wang H; Lu Y; Ma X
    Hepatology; 2021 Jan; 73(1):91-103. PubMed ID: 32150756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases.
    Wu X; Chen H; Li K; Zhang H; Li K; Tan H
    J Transl Med; 2024 May; 22(1):490. PubMed ID: 38790013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
    Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
    Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
    Han S; Cao D; Sha J; Zhu X; Chen D
    Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of m
    Wojtas MN; Pandey RR; Mendel M; Homolka D; Sachidanandam R; Pillai RS
    Mol Cell; 2017 Oct; 68(2):374-387.e12. PubMed ID: 29033321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation.
    Yuan W; Chen S; Li B; Han X; Meng B; Zou Y; Chang S
    Transl Oncol; 2022 Feb; 16():101308. PubMed ID: 34911015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.